Four analysts polled by Capital IQ called for $0.70.
Revenue for the quarter ended March 31 was $333.4 million, up from $263.5 million a year earlier. Analysts surveyed by Capital IQ projected $325.7 million.
Looking ahead, the US media and broadcasting firm said it continues to target 2022 adjusted operating income before depreciation and amortization of $360 million to $375 million.
The company's shares rose more than 4% in recent Thursday after-hours activity.
Price: 62, Change: +2.51, Percent Change: +4.22
|-- Earnings Flash (AQS) AEQUUS PHARMACEUTICALS Repor...|
|Insider Buy: Bitnile Holdings|
|Insider Buy: Macerich|
|Insider Sell: Velodyne Lidar|
|Insider Sell: Xometry|